The Global Anhydrous Dibasic Calcium Phosphate market is estimated to be valued at US$ 245.96 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period from 2024 to 2030.

Key Takeaways
Key players operating in the Anhydrous Dibasic Calcium Phosphate market include Pfizer, Sanofi, New England Biolabs, GlaxoSmithKline plc, GenScript, Thermo Fisher Scientific, Inc., Biogen, Inc., Merck & Co., Inc., Profacgen, Amgen, Inc., and Monsanto Company. Pfizer dominates the Anhydrous Dibasic Calcium Phosphate market with its broad range of food and pharmaceutical grade DBCP products.

The global Anhydrous Dibasic Calcium Phosphate Market Demand is growing significantly owing rising consumption of processed food, functional food, and nutritional supplements across various regions. DBCP finds wide applications in confectionery, processed meat, dairy products, bakery products, and nutritional supplements due to its multifunctional properties.

Major players in the Anhydrous Dibasic Calcium Phosphate market are focusing on capacity expansion and global footprint to cater to the growing demand from international markets. Companies are investing in R&D to develop new grades of anhydrous DBCP with enhanced functionality for new applications. Manufacturers are also exploring opportunities in emerging countries in Asia Pacific and Latin America through partnerships and acquisitions.

Get More Insights on Anhydrous Dibasic Calcium Phosphate Market